| CXSL2400176 | 重组人绒促性素注射液 | Recombinant Human Choriogonadotropin alfa | Injection | Biological Products(3.3) | New Drug Application | 2024-03-12 | | Suzhou Shengji Pharmaceutical Co Ltd | | | view |
| JXSL0700003 | 重组人绒促性素注射液 | Recombinant Human Choriogonadotropin alfa | Injection | Biological Products(7) | Import Drug Application | 2007-01-24 | 雪兰诺欧洲公司 | Merck Serono Europe Ltd | Certificate Issued | 2008-09-16 | view |
| JYSB1200031 | 重组人绒促性素注射液 | Recombinant Human Choriogonadotropin alfa | Injection | Biological Products | Supplementary Application | 2012-03-06 | 默克雪兰诺（北京）医药研发有限公司 | Merck Serono (Beijing) Pharmaceutical R&D Co Ltd | Certificate Issued | 2015-01-08 | view |
| JYSB1300147 | 重组人绒促性素注射液 | Recombinant Human Choriogonadotropin alfa | Injection | Biological Products | Supplementary Application | 2013-07-01 | 默克雪兰诺（北京）医药研发有限公司 | Merck Serono (Beijing) Pharmaceutical R&D Co Ltd | Certificate Issued | 2014-06-06 | view |
| JYSB1700132 | 重组人绒促性素注射液 | Recombinant Human Choriogonadotropin alfa | Injection | Biological Products | Supplementary Application | 2017-07-21 | 默克雪兰诺有限公司 | Merck Serono Co Ltd | Certificate Issued | 2018-10-24 | view |
| JYSB1900103 | 重组人绒促性素注射液 | Recombinant Human Choriogonadotropin alfa | Injection | Biological Products | Supplementary Application | 2019-05-05 | 默克雪兰诺有限公司 | Merck Serono Co Ltd | Filed | 2019-05-15 | view |
| JYSB2000069 | 重组人绒促性素注射液 | Recombinant Human Choriogonadotropin alfa | Injection | Biological Products | Supplementary Application | 2020-03-20 | 默克雪兰诺有限公司 | Merck Serono Co Ltd | Certificate Issued | 2020-06-05 | view |
| JYSB2000070 | 重组人绒促性素注射液 | Recombinant Human Choriogonadotropin alfa | Injection | Biological Products | Supplementary Application | 2020-03-05 | 默克雪兰诺有限公司 | Merck Serono Co Ltd | Filed | 2020-03-26 | view |
| JYSB2000315 | 重组人绒促性素注射液 | Recombinant Human Choriogonadotropin alfa | Injection | Biological Products | Supplementary Application | 2020-07-17 | 默克雪兰诺有限公司 | Merck Serono Co Ltd | In Review | 2020-07-16 | view |
| JYSB2000376 | 重组人绒促性素注射液 | Recombinant Human Choriogonadotropin alfa | Injection | Biological Products | Supplementary Application | 2020-08-21 | 默克雪兰诺有限公司 | Merck Serono Co Ltd | Filed | 2020-09-02 | view |
| JYSB2200089 | 重组人绒促性素注射液 | Recombinant Human Choriogonadotropin alfa | Injection | Biological Products | Supplementary Application | 2022-05-31 | | | | | view |
| JYSB2400235 | 重组人绒促性素注射液 | Recombinant Human Choriogonadotropin alfa | Injection | Biological Products | Supplementary Application | 2024-10-22 | | | | | view |
| JYSB2400238 | 重组人绒促性素注射液 | Recombinant Human Choriogonadotropin alfa | Injection | Biological Products | Supplementary Application | 2024-11-08 | | | | | view |
| JYSZ1800022 | 重组人绒促性素注射液 | Recombinant Human Choriogonadotropin alfa | Injection | Biological Products | License Renew | 2018-03-23 | 默克雪兰诺有限公司 | Merck Serono Co Ltd | Certificate Issued | 2018-10-22 | view |
| JYSZ2300014 | 重组人绒促性素注射液 | Recombinant Human Choriogonadotropin alfa | Injection | Biological Products | License Renew | 2023-03-28 | | | | | view |
